Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Korean J Anesthesiol. 2011 Apr;60(4):272-81. doi: 10.4097/kjae.2011.60.4.272. Epub 2011 Apr 26.
The aim of this study was to evaluate the effect of diabetes on the function and distribution of vascular α(1)-adrenoceptors in the abdominal aorta and distal mesenteric artery from streptozotocin (STZ)-induced diabetic rats at the level of the α(1)-adrenoceptor subtypes.
Diabetes was induced by a single intravenous injection of STZ (60 mg/kg) in 8 week-old male Sprague-Dawley rats (n = 11). Age-matched normal rats (n = 14) were used as a control group. Four weeks after STZ injection, the tilting-induced change of the mean arterial pressure was recorded. The α(1)-adrenoceptor subtypes mediating the contractions of the distal mesenteric artery and abdominal aorta were investigated using the agonist phenylephrine and subtype-selective antagonists that included prazocin, 5-methylurapidil and BMY 7378. The expressions of the α(1)-adrenoceptor subtypes of each artery were examined by immunofluorescence staining using the subtype selective antibodies.
The recovery of the mean arterial pressure was delayed after positional change in the diabetic rats. Compared with that of the normal rats, the contractile response to phenylephrine was increased in the abdominal aortas and it was decreased in the distal mesenteric arteries in the diabetic rats. In addition, compared with the normal rats, the fluorescent intensity of all the α(1)-adrenoceptor subtypes was increased in the abdominal aortas and it was decreased in the mesenteric arteries of the diabetic rats.
Diabetes increased the contractility of the abdominal aorta in response to phenylephrine, yet diabetes decreased that of the mesenteric arteries in the STZ-induced diabetic rats. Those results are mainly based on the overall change of the α(1)-adrenoceptor, and not on the change of the specific α(1)-adrenoceptor subtypes.
本研究旨在评估糖尿病对链脲佐菌素(STZ)诱导的糖尿病大鼠腹主动脉和远端肠系膜动脉血管α1-肾上腺素能受体功能和分布的影响,在α1-肾上腺素能受体亚型水平上。
8 周龄雄性 Sprague-Dawley 大鼠(n=11)经单次静脉注射 STZ(60mg/kg)诱导糖尿病。年龄匹配的正常大鼠(n=14)作为对照组。STZ 注射后 4 周,记录倾斜诱导的平均动脉压变化。使用激动剂苯肾上腺素和亚型选择性拮抗剂(包括哌唑嗪、5-甲基尿嘧啶和 BMY 7378)研究介导远端肠系膜动脉和腹主动脉收缩的α1-肾上腺素能受体亚型。使用亚型选择性抗体通过免疫荧光染色检查各动脉的α1-肾上腺素能受体亚型表达。
糖尿病大鼠位置改变后平均动脉压恢复延迟。与正常大鼠相比,糖尿病大鼠腹主动脉对苯肾上腺素的收缩反应增加,而肠系膜动脉则减少。此外,与正常大鼠相比,糖尿病大鼠腹主动脉所有α1-肾上腺素能受体亚型的荧光强度增加,而肠系膜动脉的荧光强度降低。
糖尿病增加了 STZ 诱导的糖尿病大鼠对苯肾上腺素的腹主动脉收缩性,但降低了肠系膜动脉的收缩性。这些结果主要基于α1-肾上腺素能受体的整体变化,而不是特定α1-肾上腺素能受体亚型的变化。